International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017 – P&T Community

By raymumme

International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017
P&T Community
ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin …

and more »

Read more:
International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017 – P&T Community

Related Post


categoriaSkin Stem Cells commentoComments Off on International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017 – P&T Community | dataMay 18th, 2017

About...

This author published 735 posts in this site.
Teacher, Educator, Speaker, Adult Stem Cell Advocate

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research